Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NeuroOne Medical Technologies Corporation NMTC
$1.33
+$0.04 (3.10%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
21682168.00000000
-
week52high
2.95
-
week52low
0.51
-
Revenue
171169
-
P/E TTM
-3
-
Beta
0.68546700
-
EPS
-0.50000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:00
Описание компании
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Craig-Hallum | Hold | Buy | 28 мар 2022 г. |
| Alliance Global Partners | Buy | 03 дек 2021 г. | |
| Craig-Hallum | Buy | 15 ноя 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| McClurg Ronald W. | A | 67000 | 10000 | 15 июн 2022 г. |
| McClurg Ronald W. | A | 57000 | 14000 | 10 июн 2022 г. |
| MATHIESEN JEFFREY S | A | 29230 | 29230 | 31 мая 2022 г. |
| MATHIESEN JEFFREY S | A | 66060 | 29240 | 31 мая 2022 г. |
| BUCKMAN PAUL | A | 29230 | 29230 | 31 мая 2022 г. |
| BUCKMAN PAUL | A | 60672 | 29240 | 31 мая 2022 г. |
| Andrle Edward | A | 29230 | 29230 | 31 мая 2022 г. |
| Andrle Edward | A | 43649 | 29240 | 31 мая 2022 г. |
| McClurg Ronald W. | A | 43000 | 10500 | 24 мая 2022 г. |
| McClurg Ronald W. | A | 32500 | 17500 | 20 мая 2022 г. |
Новостная лента
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
PRNewsWire
08 дек 2022 г. в 09:00
EDEN PRAIRIE, Minn. , Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal fourth quarter and full fiscal year ended September 30, 2022, and provide a corporate update, on December 13, 2022 at 4:30 PM Eastern Time.
Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week
PennyStocks
21 ноя 2022 г. в 12:59
Biotech penny stocks to watch this week. Are they a buy now?
NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q3 2022 Results - Earnings Call Transcript
Seeking Alpha
14 авг 2022 г. в 06:12
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2022 Earnings Conference Call August 11, 2022 5:30 PM ET Company Participants Dave Rosa - President and Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Alexander Nowak - Craig-Hallum Capital Group Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Third Quarter of Fiscal Year 2022 Financial Results Conference Call.
NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25
PRNewsWire
19 мая 2022 г. в 09:30
EDEN PRAIRIE, Minn. , May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will present at the H.C.
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
14 мая 2022 г. в 11:20
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Dave Rosa – Chief Executive Officer Ron Mcclurg – Chief Financial Officer Conference Call Participants Connor Stevenson – Craig-Hallum Ben Haynor – Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal 2022 Earnings Conference Call. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and its Chief Financial Officer, Ron Mcclurg.